Health and Healthcare
Theranos Death Watch Continues
Published:
Last Updated:
Theranos CEO Elizabeth Holmes presented a new blood test system as a means to diversify beyond its earlier, failed products. Based on most accounts, many scientists who saw the presentation thought it was a weak comeback attempt by a company that continues to die swiftly.
The new miniLab can run a large number of blood tests on a small amount of blood. At the launch, Holmes said:
The results we’ve presented demonstrate the inventions behind, and some of the analytical performance capabilities of, the miniLab system, a single platform that we have designed to process small sample volumes across a broad set of different test methodologies. The miniLab architecture provides a potential framework for testing in a decentralized setting, while maintaining centralized oversight. We hope to achieve FDA market authorizations of these exciting technologies in the coming years.
A very, very thin argument for the company’s turnaround. The U.S. Food and Drug Administration (FDA) already has made ruinous evaluations of earlier Theranos products. And the miniLab will take a very long time to be evaluated. All of this turnaround is to occur while Holmes is essentially banned from her own business.
The FDA has shuttered one of the Theranos labs and driven Holmes out of the blood-testing business for two years. Presumably, she will oversee the launch of the miniLab from exile.
For some odd reason, Theranos has decided to keep Holmes at the helm, instead of replacing her with an industry leader, although an industry leader probably would not take the job.
There are few industries in which a company with tainted products, along with federal investigations into its work, can survive. Medical products and services are at the top of that list.
Theranos needed to pitch a product that was bulletproof, and one for which it could make the case for a high probability of FDA approval. In its latest product release, it did neither. Theranos can’t stay in business for long.
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
